Joseph P. Porter's  Instablog

Joseph P. Porter
Send Message
I am a retired college faculty in Philosophy, with specializations in Ethics, Socio-political Theory and Rational Choice/Decision Theory. My teaching focus was on Business Ethics, Medical Ethics and Logic. After retirement I freelanced as a Grant Writer/Fund Raising Consultant. I have taught at... More
My company:
My blog:
Joseph P. Porter's Instablog
  • Biogen Idec Strikes Out Against Lou Gherig Disease 0 comments
    Jan 4, 2013 9:42 AM | about stocks: CUR

    Biogen Idec's (BBIB) dexpramipexole, a Phase III drug has apparently failed to bring about significant improvement in people suffering from Amyotrophic Lateral Sclerosis (ALS, or "Lou Gherig's Disease). Further studies with the drug appear to be unlikely. I should imagine this will bring Biogen's price down a bit - bad news tends to have that effect.

    On the positive side, this makes Neuralstem's (NYSEMKT:CUR) treatment for ALS (injecting stem cells into the patient's spinal cord) look all the more significant, as preliminary tests have shown the treatment to help control the disease.

    This also puts a little more pressure on Neuralstem to keep up with the good work, and to keep posting good news.

    Disclosure: I am long CUR.

    Stocks: CUR
Back To Joseph P. Porter's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • $CUR up $0.27 @1:20 - can't find any news for big jump (15%!) - anyone know what's going on?? Very smiley face about this.
    Sep 24, 2015
  • $CUR earnings didn't help their case much - @ ~ $2.38. Will take great news somewhere to bring stock back up.
    Mar 16, 2015
  • Ignore ETF Expense Ratios? Maybe
    Dec 18, 2014
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.